PATENT CLAIM ANALYSIS

Application Number: 15989860
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["424", "133100"]

Abstract:
Pharmaceutical composition comprising antibodies or antigen binding fragments thereof that bind to SSEA-4 are disclosed herein, as well as methods of use thereof. Methods of use include, without limitation, cancer therapies and diagnostics. The antibodies of the disclosure can bind to certain cancer cell surfaces. Exemplary targets of the antibodies disclosed herein can include carcinomas, such as those in brain, lung, breast, mouse, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervix, ovary, and/or prostate cancer.

Claim (Index 2):
The isolated antibody of  claim 1 , which further binds to Fuc\u03b11\u21922Gal\u03b21\u21923GalNAc\u03b21\u21923Gal\u03b11\u21924Gal\u03b2\u21924Glc\u03b21 and Gal\u03b21\u21923GalNAc\u03b21\u21923Gal\u03b11\u21924Gal\u03b21\u21924Glc\u03b21.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.61667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14599174', '14798312', '15011544', '15011543', '15683685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7741661384039781
- 35 USC 102 Novelty (BERT): 0.6805501387875916
- Combined Prediction Score: 0.7648045384423394
- Mean Citation Score: 719.916168
- Max Citation Score: 882.62274
- Similarity Product: 655.185199019909

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test